Concepedia

Kristina Ellwanger

KE

Statistics

Publications

18

Citations

1.2K

H-Index

16

Active since

2007

Affiliations

Affimed Therapeutics (Germany)(Current)

Heidelberg University

DKFZ-ZMBH Alliance

German Cancer Research Center

Harvard University

Kristina Ellwanger is an author at Affimed Therapeutics (Germany) specializing in immunology, life sciences, and bispecific antibodies.

Publications per year

2007–2022

18

Publications

18

Loss of Dickkopf-1 Restores Neurogenesis in Old Age and Counteracts Cognitive Decline

Désirée R. Seib, Nina S. Corsini, Kristina Ellwanger et al. · Cell stem cell · 2013 · 299 citations · Full text

, , +15

A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19<sup>+</sup>tumor cells

Uwe Reusch, Johannes Duell, Kristina Ellwanger et al. · mAbs · 2015 · 127 citations · Full text

, , +17

Targeted Disruption of the Wnt Regulator Kremen Induces Limb Defects and High Bone Density

Kristina Ellwanger, Hiroaki Saito, Philippe Clément-Lacroix et al. · Molecular and Cellular Biology · 2008 · 108 citations

, , +17

Characterization of CD33/CD3 Tetravalent Bispecific Tandem Diabodies (TandAbs) for the Treatment of Acute Myeloid Leukemia

Uwe Reusch, Kimberly H. Harrington, Chelsea J. Gudgeon et al. · Clinical Cancer Research · 2016 · 89 citations · Full text

, , +17

Redirected optimized cell killing (ROCK®): A highly versatile multispecific fit-for-purpose antibody platform for engaging innate immunity

Kristina Ellwanger, Uwe Reusch, Ivica Fucek et al. · mAbs · 2019 · 65 citations · Full text

, , +17

1–5 of 18